$13.77
0.413.07%
In chiusura: -
$13.87
0.10.73%
After hour: Oct 24, 4:16 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
10x Genomics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 6
Stima EPS
$-0.150
Stima dei ricavi trimestrali
$142.47M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$644.47M
Analizza lo storico degli utili di 10x Genomics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
TXG | 10x Genomics | -$0.30 | -$0.15 | — | — | $151.65M | $142.47M | — | — | 11/06/2025 | |
TXG | 10x Genomics | -$0.32 | -$0.19 | $0.28 | 247.37% | $153.10M | $139.48M | $172.90M | 23.96% | 08/07/2025 | |
TXG | 10x Genomics | -$0.50 | -$0.29 | -$0.28 | 3.45% | $141.01M | $131.91M | $154.88M | 17.42% | 05/08/2025 | |
TXG | 10x Genomics | -$0.24 | -$0.11 | -$0.40 | -263.64% | $183.98M | $164.98M | $165.02M | 0.02% | 02/12/2025 | |
TXG | 10x Genomics | -$0.79 | -$0.34 | -$0.30 | 11.76% | $153.64M | $158.63M | $151.65M | -4.40% | 10/29/2024 | |
TXG | 10x Genomics | -$0.53 | -$0.47 | -$0.32 | 31.91% | $146.82M | $150.74M | $153.10M | 1.57% | 08/08/2024 | |
TXG | 10x Genomics | -$0.44 | -$0.50 | -$0.50 | 0.00% | $134.28M | $142.24M | $141.01M | -0.87% | 04/30/2024 | |
TXG | 10x Genomics | -$0.15 | -$0.36 | -$0.24 | 33.33% | $156.23M | $182.80M | $183.98M | 0.64% | 02/15/2024 | |
TXG | 10x Genomics | -$0.37 | -$0.46 | -$0.44 | 4.35% | $131.07M | $151.26M | $153.64M | 1.58% | 11/02/2023 | |
TXG | 10x Genomics | -$0.57 | -$0.39 | -$0.53 | -35.90% | $114.61M | $138.97M | $146.82M | 5.65% | 08/03/2023 | |
TXG | 10x Genomics | -$0.38 | -$0.37 | -$0.44 | -18.92% | $114.50M | $128.82M | $134.28M | 4.24% | 05/03/2023 | |
TXG | 10x Genomics | -$0.16 | -$0.31 | -$0.15 | 51.61% | $143.53M | $148.69M | $156.23M | 5.07% | 02/15/2023 | |
TXG | 10x Genomics | -$0.15 | -$0.46 | -$0.37 | 19.57% | $125.30M | $129.58M | $131.07M | 1.15% | 11/02/2022 | |
TXG | 10x Genomics | -$0.10 | -$0.39 | -$0.57 | -46.15% | $115.84M | $117.19M | $114.61M | -2.20% | 08/08/2022 | |
TXG | 10x Genomics | -$0.11 | -$0.31 | -$0.38 | -22.58% | $105.82M | $113.34M | $114.50M | 1.02% | 05/04/2022 | |
TXG | 10x Genomics | -$0.08 | -$0.09 | -$0.16 | -77.78% | $112.22M | $148.53M | $143.53M | -3.37% | 02/16/2022 | |
TXG | 10x Genomics | -$0.65 | -$0.20 | -$0.15 | 25.00% | $71.82M | $122.62M | $125.30M | 2.18% | 11/03/2021 | |
TXG | 10x Genomics | -$0.41 | -$0.26 | -$0.10 | 61.54% | $42.91M | $112.85M | $115.84M | 2.65% | 08/04/2021 | |
TXG | 10x Genomics | -$0.22 | -$0.27 | -$0.11 | 59.26% | $71.91M | $102.51M | $105.82M | 3.23% | 05/05/2021 | |
TXG | 10x Genomics | -$0.07 | -$0.23 | -$0.08 | 65.22% | $75.29M | $100.40M | $112.22M | 11.77% | 02/17/2021 | |
TXG | 10x Genomics | -$0.33 | -$0.30 | -$0.65 | -116.67% | $61.21M | $61.23M | $71.82M | 17.29% | 11/10/2020 |
10x Genomics (TXG) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-07 | $0.28 | $-0.19 | 247.4 % |
| Q1 | 2025-05-08 | $-0.28 | $-0.29 | 3.45 % |
| Q4 | 2025-02-12 | $-0.40 | $-0.11 | -263.6 % |
| Q3 | 2024-10-29 | $-0.30 | $-0.34 | 11.8 % |
10x Genomics (TXG) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-07 | $172.90M | $139.48M | 24.0 % |
| Q1 | 2025-05-08 | $154.88M | $131.91M | 17.4 % |
| Q4 | 2025-02-12 | $165.02M | $164.98M | 0.02 % |
| Q3 | 2024-10-29 | $151.65M | $158.63M | -4.40 % |
FAQ
Quando 10x Genomics (NASDAQ:TXG) riporterà gli utili?
Si prevede che 10x Genomics (TXG) fornisca risultati il novembre 6, 2025. Gli ultimi risultati sono stati pubblicati il agosto 7, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di 10x Genomics (NASDAQ:TXG)?
L'EPS effettivo era $0.28, che superato la stima di $-0.19.
Quali sono state le entrate di 10x Genomics (NASDAQ:TXG)?
Le entrate effettive sono state $172.9M, che superato la stima di $139.5M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.